Related Experiment Videos
Phase I clinical trial with a combination of methotrexate and mitomycin C
Cancer Chemotherapy and Pharmacology
|January 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Distribution of Fracture Sites in Postmenopausal Overweight and Obese Women: The FRISBEE Study.
Calcified tissue international·2022
Intensification versus combination: revisiting the past and envisioning the future of LDHA inhibitors.
Cancer chemotherapy and pharmacology·2026
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026